SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

被引：427
|
作者：
Poland, Gregory A. [1 ,2 ]
Ovsyannikova, Inna G. [1 ,2 ]
Kennedy, Richard B. [1 ,2 ]
机构：
[1] Mayo Clin, Mayo Clin Vaccine Res Grp, Rochester, MN USA
[2] Mayo Clin, Div Gen Internal Med, Rochester, MN USA
来源：
LANCET | 2020年 / 396卷 / 10262期
关键词：
ANTIBODY-DEPENDENT ENHANCEMENT; COVID-19; INFECTION; DISEASE; CELLS;
D O I：
10.1016/S0140-6736(20)32137-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Understanding immune responses to severe acute respiratory syndrome coronavirus 2 is crucial to understanding disease pathogenesis and the usefulness of bridge therapies, such as hyperimmune globulin and convalescent human plasma, and to developing vaccines, antivirals, and monoclonal antibodies. A mere 11 months ago, the canvas we call COVID-19 was blank. Scientists around the world have worked collaboratively to fill in this blank canvas. In this Review, we discuss what is currently known about human humoral and cellular immune responses to severe acute respiratory syndrome coronavirus 2 and relate this knowledge to the COVID-19 vaccines currently in phase 3 clinical trials.
引用
收藏
页码：1595 / 1606
页数：12
相关论文
共 50 条
  • [31] Inactivated vaccine for SARS-CoV-2
    Risson, Emma
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (6) : 353 - 353
  • [32] Russian SARS-CoV-2 vaccine
    Caddy, Sarah
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [33] Racing for a SARS-CoV-2 vaccine
    Tuereci, Oezlem
    Sahin, Ugur
    EMBO MOLECULAR MEDICINE, 2021, 13 (11)
  • [34] The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
    Yu, Haiyun
    Guan, Fei
    Miller, Heather
    Lei, Jiahui
    Liu, Chaohong
    EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
  • [35] A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity
    Bellier, Bertrand
    Saura, Alicia
    Lujan, Lucas A.
    Molina, Cecilia R.
    Lujan, Hugo D.
    Klatzmann, David
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
    Tobias, Joshua
    Steinberger, Peter
    Wilkinson, Joy
    Klais, Gloria
    Kundi, Michael
    Wiedermann, Ursula
    VACCINES, 2024, 12 (07)
  • [37] A Vaccine of SARS-CoV-2 S Protein RBD Induces Protective Immunity
    Qu, Qiaoqiao
    Hao, Pengfei
    Xu, Wang
    Li, Letian
    Jiang, Yuhang
    Xu, Zhiqiang
    Chen, Jing
    Gao, Zihan
    Pang, Zhaoxia
    Jin, Ningyi
    Li, Chang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [38] Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates
    Molly E. Gallagher
    Andrew J. Sieben
    Kristin N. Nelson
    Alicia N. M. Kraay
    Walter A. Orenstein
    Ben Lopman
    Andreas Handel
    Katia Koelle
    Nature Medicine, 2021, 27 : 4 - 5
  • [39] Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates
    Behr, Marcel A.
    Divangahi, Maziar
    Schurr, Erwin
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (02): : 189 - 191
  • [40] Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates
    Gallagher, Molly E.
    Sieben, Andrew J.
    Nelson, Kristin N.
    Kraay, Alicia N. M.
    Orenstein, Walter A.
    Lopman, Ben
    Handel, Andreas
    Koelle, Katia
    NATURE MEDICINE, 2021, 27 (01) : 4 - 5
12345